Trial Profile
A Double-blind, Placebo-Controlled, Randomized Study of the Efficacy of Dextromethorphan as Add-On Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 30 Jun 2016
Price :
$35
*
At a glance
- Drugs Dextromethorphan (Primary) ; Risperidone (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 06 Sep 2010 New trial record